Selected research
Industry Research
Preventable Vaccines Industry Research Report 2026
Market perspective
The global Preventable Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Preventable Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Preventable Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Preventable Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Preventable Vaccines include Bausch Health, Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, Janssen Pharmaceuticals, LG Life Sciences, Lupin and Mitsubishi Tanabe Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Preventable Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Preventable Vaccines Market by Company
Bausch Health
Bavarian Nordic
Bharat Biotech
Crucell
Dynavax
Janssen Pharmaceuticals
LG Life Sciences
Lupin
Mitsubishi Tanabe Pharma
Panacea Biotec
Protein Sciences
S K Chemicals
Serum Institute of India
Sinovac Biotech
Takeda Pharmaceutical
AstraZeneca
Baxter
GlaxoSmithKline
Pfizer
Roche
Merck
Novartis
Sanofi
Shenzhen Kangtai Biological Products
Abbott
Preventable Vaccines Segment by Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Preventable Vaccines Segment by Application
Bacterial Diseases
Virus Diseases
Preventable Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventable Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preventable Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventable Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Preventable Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Preventable Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Preventable Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Preventable Vaccines Sales (W Units) of Manufacturers (2021-2026)
Table 7. Global Preventable Vaccines Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Preventable Vaccines Revenue of Manufacturers (2021-2026)
Table 9. Global Preventable Vaccines Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Preventable Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Preventable Vaccines Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Preventable Vaccines, Product Type & Application
Table 14. Global Preventable Vaccines Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Preventable Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Bausch Health Company Information
Table 19. Bausch Health Business Overview
Table 20. Bausch Health Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Bausch Health Preventable Vaccines Product Portfolio
Table 22. Bausch Health Recent Developments
Table 23. Bavarian Nordic Company Information
Table 24. Bavarian Nordic Business Overview
Table 25. Bavarian Nordic Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Bavarian Nordic Preventable Vaccines Product Portfolio
Table 27. Bavarian Nordic Recent Developments
Table 28. Bharat Biotech Company Information
Table 29. Bharat Biotech Business Overview
Table 30. Bharat Biotech Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Bharat Biotech Preventable Vaccines Product Portfolio
Table 32. Bharat Biotech Recent Developments
Table 33. Crucell Company Information
Table 34. Crucell Business Overview
Table 35. Crucell Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Crucell Preventable Vaccines Product Portfolio
Table 37. Crucell Recent Developments
Table 38. Dynavax Company Information
Table 39. Dynavax Business Overview
Table 40. Dynavax Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Dynavax Preventable Vaccines Product Portfolio
Table 42. Dynavax Recent Developments
Table 43. Janssen Pharmaceuticals Company Information
Table 44. Janssen Pharmaceuticals Business Overview
Table 45. Janssen Pharmaceuticals Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Janssen Pharmaceuticals Preventable Vaccines Product Portfolio
Table 47. Janssen Pharmaceuticals Recent Developments
Table 48. LG Life Sciences Company Information
Table 49. LG Life Sciences Business Overview
Table 50. LG Life Sciences Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. LG Life Sciences Preventable Vaccines Product Portfolio
Table 52. LG Life Sciences Recent Developments
Table 53. Lupin Company Information
Table 54. Lupin Business Overview
Table 55. Lupin Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Lupin Preventable Vaccines Product Portfolio
Table 57. Lupin Recent Developments
Table 58. Mitsubishi Tanabe Pharma Company Information
Table 59. Mitsubishi Tanabe Pharma Business Overview
Table 60. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio
Table 62. Mitsubishi Tanabe Pharma Recent Developments
Table 63. Panacea Biotec Company Information
Table 64. Panacea Biotec Business Overview
Table 65. Panacea Biotec Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Panacea Biotec Preventable Vaccines Product Portfolio
Table 67. Panacea Biotec Recent Developments
Table 68. Protein Sciences Company Information
Table 69. Protein Sciences Business Overview
Table 70. Protein Sciences Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Protein Sciences Preventable Vaccines Product Portfolio
Table 72. Protein Sciences Recent Developments
Table 73. S K Chemicals Company Information
Table 74. S K Chemicals Business Overview
Table 75. S K Chemicals Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. S K Chemicals Preventable Vaccines Product Portfolio
Table 77. S K Chemicals Recent Developments
Table 78. Serum Institute of India Company Information
Table 79. Serum Institute of India Business Overview
Table 80. Serum Institute of India Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Serum Institute of India Preventable Vaccines Product Portfolio
Table 82. Serum Institute of India Recent Developments
Table 83. Sinovac Biotech Company Information
Table 84. Sinovac Biotech Business Overview
Table 85. Sinovac Biotech Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sinovac Biotech Preventable Vaccines Product Portfolio
Table 87. Sinovac Biotech Recent Developments
Table 88. Takeda Pharmaceutical Company Information
Table 89. Takeda Pharmaceutical Business Overview
Table 90. Takeda Pharmaceutical Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Takeda Pharmaceutical Preventable Vaccines Product Portfolio
Table 92. Takeda Pharmaceutical Recent Developments
Table 93. AstraZeneca Company Information
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. AstraZeneca Preventable Vaccines Product Portfolio
Table 97. AstraZeneca Recent Developments
Table 98. Baxter Company Information
Table 99. Baxter Business Overview
Table 100. Baxter Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Baxter Preventable Vaccines Product Portfolio
Table 102. Baxter Recent Developments
Table 103. GlaxoSmithKline Company Information
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. GlaxoSmithKline Preventable Vaccines Product Portfolio
Table 107. GlaxoSmithKline Recent Developments
Table 108. Pfizer Company Information
Table 109. Pfizer Business Overview
Table 110. Pfizer Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Pfizer Preventable Vaccines Product Portfolio
Table 112. Pfizer Recent Developments
Table 113. Roche Company Information
Table 114. Roche Business Overview
Table 115. Roche Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Roche Preventable Vaccines Product Portfolio
Table 117. Roche Recent Developments
Table 118. Merck Company Information
Table 119. Merck Business Overview
Table 120. Merck Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Merck Preventable Vaccines Product Portfolio
Table 122. Merck Recent Developments
Table 123. Novartis Company Information
Table 124. Novartis Business Overview
Table 125. Novartis Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Novartis Preventable Vaccines Product Portfolio
Table 127. Novartis Recent Developments
Table 128. Sanofi Company Information
Table 129. Sanofi Business Overview
Table 130. Sanofi Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Sanofi Preventable Vaccines Product Portfolio
Table 132. Sanofi Recent Developments
Table 133. Shenzhen Kangtai Biological Products Company Information
Table 134. Shenzhen Kangtai Biological Products Business Overview
Table 135. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio
Table 137. Shenzhen Kangtai Biological Products Recent Developments
Table 138. Abbott Company Information
Table 139. Abbott Business Overview
Table 140. Abbott Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Abbott Preventable Vaccines Product Portfolio
Table 142. Abbott Recent Developments
Table 143. Global Preventable Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 144. Global Preventable Vaccines Sales by Region (2021-2026) & (W Units)
Table 145. Global Preventable Vaccines Sales Market Share by Region (2021-2026)
Table 146. Global Preventable Vaccines Sales by Region (2027-2032) & (W Units)
Table 147. Global Preventable Vaccines Sales Market Share by Region (2027-2032)
Table 148. Global Preventable Vaccines Revenue by Region (2021-2026) & (US$ Million)
Table 149. Global Preventable Vaccines Revenue Market Share by Region (2021-2026)
Table 150. Global Preventable Vaccines Revenue by Region (2027-2032) & (US$ Million)
Table 151. Global Preventable Vaccines Revenue Market Share by Region (2027-2032)
Table 152. North America Preventable Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. North America Preventable Vaccines Sales by Country (2021-2026) & (W Units)
Table 154. North America Preventable Vaccines Sales by Country (2027-2032) & (W Units)
Table 155. North America Preventable Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 156. North America Preventable Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 157. Europe Preventable Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. Europe Preventable Vaccines Sales by Country (2021-2026) & (W Units)
Table 159. Europe Preventable Vaccines Sales by Country (2027-2032) & (W Units)
Table 160. Europe Preventable Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 161. Europe Preventable Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 162. Asia Pacific Preventable Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. Asia Pacific Preventable Vaccines Sales by Country (2021-2026) & (W Units)
Table 164. Asia Pacific Preventable Vaccines Sales by Country (2027-2032) & (W Units)
Table 165. Asia Pacific Preventable Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 166. Asia Pacific Preventable Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 167. South America Preventable Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 168. South America Preventable Vaccines Sales by Country (2021-2026) & (W Units)
Table 169. South America Preventable Vaccines Sales by Country (2027-2032) & (W Units)
Table 170. South America Preventable Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 171. South America Preventable Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 172. Middle East and Africa Preventable Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 173. Middle East and Africa Preventable Vaccines Sales by Country (2021-2026) & (W Units)
Table 174. Middle East and Africa Preventable Vaccines Sales by Country (2027-2032) & (W Units)
Table 175. Middle East and Africa Preventable Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 176. Middle East and Africa Preventable Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 177. Global Preventable Vaccines Sales by Type (2021-2026) & (W Units)
Table 178. Global Preventable Vaccines Sales by Type (2027-2032) & (W Units)
Table 179. Global Preventable Vaccines Sales Market Share by Type (2021-2026)
Table 180. Global Preventable Vaccines Sales Market Share by Type (2027-2032)
Table 181. Global Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million)
Table 182. Global Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million)
Table 183. Global Preventable Vaccines Revenue Market Share by Type (2021-2026)
Table 184. Global Preventable Vaccines Revenue Market Share by Type (2027-2032)
Table 185. Global Preventable Vaccines Price by Type (2021-2026) & (US$/Unit)
Table 186. Global Preventable Vaccines Price by Type (2027-2032) & (US$/Unit)
Table 187. Global Preventable Vaccines Sales by Application (2021-2026) & (W Units)
Table 188. Global Preventable Vaccines Sales by Application (2027-2032) & (W Units)
Table 189. Global Preventable Vaccines Sales Market Share by Application (2021-2026)
Table 190. Global Preventable Vaccines Sales Market Share by Application (2027-2032)
Table 191. Global Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million)
Table 192. Global Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million)
Table 193. Global Preventable Vaccines Revenue Market Share by Application (2021-2026)
Table 194. Global Preventable Vaccines Revenue Market Share by Application (2027-2032)
Table 195. Global Preventable Vaccines Price by Application (2021-2026) & (US$/Unit)
Table 196. Global Preventable Vaccines Price by Application (2027-2032) & (US$/Unit)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Preventable Vaccines Distributors List
Table 200. Preventable Vaccines Customers List
Table 201. Preventable Vaccines Industry Trends
Table 202. Preventable Vaccines Industry Drivers
Table 203. Preventable Vaccines Industry Restraints
Table 204. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Preventable Vaccines Product Image
Figure 5. Global Preventable Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Preventable Vaccines Market Size (2021-2032) & (US$ Million)
Figure 7. Global Preventable Vaccines Sales (2021-2032) & (W Units)
Figure 8. Global Preventable Vaccines Average Price (US$/Unit) & (2021-2032)
Figure 9. Adult Preventable Vaccines Product Image
Figure 10. Pediatric Preventable Vaccines Product Image
Figure 11. Bacterial Diseases Product Image
Figure 12. Virus Diseases Product Image
Figure 13. Global Preventable Vaccines Revenue Share by Manufacturers in 2025
Figure 14. Global Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Preventable Vaccines Players Market Share by Revenue in 2025
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 17. Global Preventable Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 18. Global Preventable Vaccines Sales by Region in 2025
Figure 19. Global Preventable Vaccines Revenue by Region in 2025
Figure 20. North America Preventable Vaccines Market Size by Country in 2025
Figure 21. North America Preventable Vaccines Sales Market Share by Country (2021-2032)
Figure 22. North America Preventable Vaccines Revenue Market Share by Country (2021-2032)
Figure 23. United States Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 24. Canada Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Mexico Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Preventable Vaccines Market Size by Country in 2025
Figure 27. Europe Preventable Vaccines Sales Market Share by Country (2021-2032)
Figure 28. Europe Preventable Vaccines Revenue Market Share by Country (2021-2032)
Figure 29. Germany Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Russia Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Spain Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Netherlands Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Switzerland Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Sweden Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Poland Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Asia Pacific Preventable Vaccines Market Size by Country in 2025
Figure 40. Asia Pacific Preventable Vaccines Sales Market Share by Country (2021-2032)
Figure 41. Asia Pacific Preventable Vaccines Revenue Market Share by Country (2021-2032)
Figure 42. China Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Japan Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. South Korea Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. India Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Australia Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Taiwan Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South America Preventable Vaccines Market Size by Country in 2025
Figure 51. South America Preventable Vaccines Sales Market Share by Country (2021-2032)
Figure 52. South America Preventable Vaccines Revenue Market Share by Country (2021-2032)
Figure 53. Brazil Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Argentina Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Chile Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Middle East and Africa Preventable Vaccines Market Size by Country in 2025
Figure 57. Middle East and Africa Preventable Vaccines Sales Market Share by Country (2021-2032)
Figure 58. Middle East and Africa Preventable Vaccines Revenue Market Share by Country (2021-2032)
Figure 59. Egypt Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. South Africa Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Israel Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Türkiye Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. GCC Countries Preventable Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Global Preventable Vaccines Sales Market Share by Type (2021-2032)
Figure 65. Global Preventable Vaccines Revenue Market Share by Type (2021-2032)
Figure 66. Global Preventable Vaccines Price (US$/Unit) by Type (2021-2032)
Figure 67. Global Preventable Vaccines Sales Market Share by Application (2021-2032)
Figure 68. Global Preventable Vaccines Revenue Market Share by Application (2021-2032)
Figure 69. Global Preventable Vaccines Price (US$/Unit) by Application (2021-2032)
Figure 70. Preventable Vaccines Value Chain
Figure 71. Preventable Vaccines Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Preventable Vaccines Industry Opportunities and Challenges
Scope & coverage.
Types
- Adult Preventable Vaccines
- Pediatric Preventable Vaccines
Applications
- Bacterial Diseases
- Virus Diseases
Companies covered
- Bausch Health
- Bavarian Nordic
- Bharat Biotech
- Crucell
- Dynavax
- Janssen Pharmaceuticals
- LG Life Sciences
- Lupin
- Mitsubishi Tanabe Pharma
- Panacea Biotec
- Protein Sciences
- S K Chemicals
- Serum Institute of India
- Sinovac Biotech
- Takeda Pharmaceutical
- AstraZeneca
- Baxter
- GlaxoSmithKline
- Pfizer
- Roche
- Merck
- Novartis
- Sanofi
- Shenzhen Kangtai Biological Products
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Preventable Vaccines Market Size (2021-2032)
- 2.2.2 Global Preventable Vaccines Sales (2021-2032)
- 2.2.3 Global Preventable Vaccines Market Average Price (2021-2032)
- 2.3 Preventable Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Adult Preventable Vaccines
- 2.3.3 Pediatric Preventable Vaccines
- 2.4 Preventable Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Bacterial Diseases
- 2.4.3 Virus Diseases
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Preventable Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Preventable Vaccines Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Preventable Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Preventable Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Preventable Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Preventable Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Preventable Vaccines, Established Date
- 3.9 Global Preventable Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bausch Health
- 4.1.1 Bausch Health Company Information
- 4.1.2 Bausch Health Business Overview
- 4.1.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bausch Health Preventable Vaccines Product Portfolio
- 4.1.5 Bausch Health Recent Developments
- 4.2 Bavarian Nordic
- 4.2.1 Bavarian Nordic Company Information
- 4.2.2 Bavarian Nordic Business Overview
- 4.2.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bavarian Nordic Preventable Vaccines Product Portfolio
- 4.2.5 Bavarian Nordic Recent Developments
- 4.3 Bharat Biotech
- 4.3.1 Bharat Biotech Company Information
- 4.3.2 Bharat Biotech Business Overview
- 4.3.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bharat Biotech Preventable Vaccines Product Portfolio
- 4.3.5 Bharat Biotech Recent Developments
- 4.4 Crucell
- 4.4.1 Crucell Company Information
- 4.4.2 Crucell Business Overview
- 4.4.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Crucell Preventable Vaccines Product Portfolio
- 4.4.5 Crucell Recent Developments
- 4.5 Dynavax
- 4.5.1 Dynavax Company Information
- 4.5.2 Dynavax Business Overview
- 4.5.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dynavax Preventable Vaccines Product Portfolio
- 4.5.5 Dynavax Recent Developments
- 4.6 Janssen Pharmaceuticals
- 4.6.1 Janssen Pharmaceuticals Company Information
- 4.6.2 Janssen Pharmaceuticals Business Overview
- 4.6.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Janssen Pharmaceuticals Preventable Vaccines Product Portfolio
- 4.6.5 Janssen Pharmaceuticals Recent Developments
- 4.7 LG Life Sciences
- 4.7.1 LG Life Sciences Company Information
- 4.7.2 LG Life Sciences Business Overview
- 4.7.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LG Life Sciences Preventable Vaccines Product Portfolio
- 4.7.5 LG Life Sciences Recent Developments
- 4.8 Lupin
- 4.8.1 Lupin Company Information
- 4.8.2 Lupin Business Overview
- 4.8.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lupin Preventable Vaccines Product Portfolio
- 4.8.5 Lupin Recent Developments
- 4.9 Mitsubishi Tanabe Pharma
- 4.9.1 Mitsubishi Tanabe Pharma Company Information
- 4.9.2 Mitsubishi Tanabe Pharma Business Overview
- 4.9.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio
- 4.9.5 Mitsubishi Tanabe Pharma Recent Developments
- 4.10 Panacea Biotec
- 4.10.1 Panacea Biotec Company Information
- 4.10.2 Panacea Biotec Business Overview
- 4.10.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Panacea Biotec Preventable Vaccines Product Portfolio
- 4.10.5 Panacea Biotec Recent Developments
- 4.11 Protein Sciences
- 4.11.1 Protein Sciences Company Information
- 4.11.2 Protein Sciences Business Overview
- 4.11.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Protein Sciences Preventable Vaccines Product Portfolio
- 4.11.5 Protein Sciences Recent Developments
- 4.12 S K Chemicals
- 4.12.1 S K Chemicals Company Information
- 4.12.2 S K Chemicals Business Overview
- 4.12.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 S K Chemicals Preventable Vaccines Product Portfolio
- 4.12.5 S K Chemicals Recent Developments
- 4.13 Serum Institute of India
- 4.13.1 Serum Institute of India Company Information
- 4.13.2 Serum Institute of India Business Overview
- 4.13.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Serum Institute of India Preventable Vaccines Product Portfolio
- 4.13.5 Serum Institute of India Recent Developments
- 4.14 Sinovac Biotech
- 4.14.1 Sinovac Biotech Company Information
- 4.14.2 Sinovac Biotech Business Overview
- 4.14.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sinovac Biotech Preventable Vaccines Product Portfolio
- 4.14.5 Sinovac Biotech Recent Developments
- 4.15 Takeda Pharmaceutical
- 4.15.1 Takeda Pharmaceutical Company Information
- 4.15.2 Takeda Pharmaceutical Business Overview
- 4.15.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Takeda Pharmaceutical Preventable Vaccines Product Portfolio
- 4.15.5 Takeda Pharmaceutical Recent Developments
- 4.16 AstraZeneca
- 4.16.1 AstraZeneca Company Information
- 4.16.2 AstraZeneca Business Overview
- 4.16.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 AstraZeneca Preventable Vaccines Product Portfolio
- 4.16.5 AstraZeneca Recent Developments
- 4.17 Baxter
- 4.17.1 Baxter Company Information
- 4.17.2 Baxter Business Overview
- 4.17.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Baxter Preventable Vaccines Product Portfolio
- 4.17.5 Baxter Recent Developments
- 4.18 GlaxoSmithKline
- 4.18.1 GlaxoSmithKline Company Information
- 4.18.2 GlaxoSmithKline Business Overview
- 4.18.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 GlaxoSmithKline Preventable Vaccines Product Portfolio
- 4.18.5 GlaxoSmithKline Recent Developments
- 4.19 Pfizer
- 4.19.1 Pfizer Company Information
- 4.19.2 Pfizer Business Overview
- 4.19.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Pfizer Preventable Vaccines Product Portfolio
- 4.19.5 Pfizer Recent Developments
- 4.20 Roche
- 4.20.1 Roche Company Information
- 4.20.2 Roche Business Overview
- 4.20.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Roche Preventable Vaccines Product Portfolio
- 4.20.5 Roche Recent Developments
- 4.21 Merck
- 4.21.1 Merck Company Information
- 4.21.2 Merck Business Overview
- 4.21.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Merck Preventable Vaccines Product Portfolio
- 4.21.5 Merck Recent Developments
- 4.22 Novartis
- 4.22.1 Novartis Company Information
- 4.22.2 Novartis Business Overview
- 4.22.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Novartis Preventable Vaccines Product Portfolio
- 4.22.5 Novartis Recent Developments
- 4.23 Sanofi
- 4.23.1 Sanofi Company Information
- 4.23.2 Sanofi Business Overview
- 4.23.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Sanofi Preventable Vaccines Product Portfolio
- 4.23.5 Sanofi Recent Developments
- 4.24 Shenzhen Kangtai Biological Products
- 4.24.1 Shenzhen Kangtai Biological Products Company Information
- 4.24.2 Shenzhen Kangtai Biological Products Business Overview
- 4.24.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio
- 4.24.5 Shenzhen Kangtai Biological Products Recent Developments
- 4.25 Abbott
- 4.25.1 Abbott Company Information
- 4.25.2 Abbott Business Overview
- 4.25.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 Abbott Preventable Vaccines Product Portfolio
- 4.25.5 Abbott Recent Developments
5 Global Preventable Vaccines Market Scenario by Region
- 5.1 Global Preventable Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Preventable Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Preventable Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Preventable Vaccines Sales by Region: 2027-2032
- 5.3 Global Preventable Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Preventable Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Preventable Vaccines Revenue by Region: 2027-2032
- 5.4 North America Preventable Vaccines Market Facts & Figures by Country
- 5.4.1 North America Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Preventable Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Preventable Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Preventable Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Preventable Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Preventable Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Preventable Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Preventable Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Preventable Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Preventable Vaccines Market Facts & Figures by Country
- 5.7.1 South America Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Preventable Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Preventable Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Preventable Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Preventable Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Preventable Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Preventable Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Preventable Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Preventable Vaccines Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Preventable Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Preventable Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Preventable Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Preventable Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Preventable Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Preventable Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Preventable Vaccines Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Preventable Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Preventable Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Preventable Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Preventable Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Preventable Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Preventable Vaccines Value Chain Analysis
- 8.1.1 Preventable Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Preventable Vaccines Production Mode & Process
- 8.2 Preventable Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Preventable Vaccines Distributors
- 8.2.3 Preventable Vaccines Customers
9 Global Preventable Vaccines Analyzing Market Dynamics
- 9.1 Preventable Vaccines Industry Trends
- 9.2 Preventable Vaccines Industry Drivers
- 9.3 Preventable Vaccines Industry Opportunities and Challenges
- 9.4 Preventable Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst